Table 1.
Sample | Chr13 z-score | Chr18 z-score | Chr21 z-score | Fetal fraction (%) | Gestational age (p.m.) | NIPT result | Fetus A karyotype | Fetus B karyotype | Invasive method |
---|---|---|---|---|---|---|---|---|---|
RDLN015823 | 0.0 | 0.0 | −0.4 | 37 | 10 + 6 | negative | 46,XX | 46,XY | CVS |
RDLN015835 | −0.6 | 0.9 | 0.7 | 35 | 12 + 6 | negative | 46,XY | 46,XX | CVS |
RDLN015916 | 1.8 | 1.9 | 0.8 | 24 | 16 + 2 | negative | 46,XY | 46,XY | AC |
RDLN016042 | 0.9 | 0.5 | 1.0 | 23 | 17 + 4 | negative | 46,XX | 46,XY | AC |
RDLN016047 | 1.3 | 0.7 | −1.6 | 45 | 13 + 5 | negative | 46,XY | 46,XY | CVS |
RDLN016114 | −0.9 | −0.2 | 8.4 | 29 | 14 + 4 | T21 positive | 47,XY,+21 | 46,XX | CVS |
RDLN016116 | −0.4 | 0.7 | 4.4 | 20 | 13 + 4 | T21 positive | 47,XX,+21 | 46,XX | CVS |
RDLN016450 | −0.1 | 1.4 | 8.4 | 31 | 16 + 0 | T21 positive | 47,XX,+21 | 46,XX | AC |
RDLN016457 | 1.0 | 0.9 | −0.3 | 22 | 17 + 5 | negative | 46,XX | 46,XY | AC |
RDLN016474 | 0.8 | 0.3 | 5.4 | 16 | 18 + 4 | T21 positive | 47,XX,+21 | 46,XX | AC |
RDLN016519 | 0.2 | −1.0 | 0.2 | 20 | 15 + 0 | negative | 46,XX | 46,XX | AC |
RDLN016778 | 0.2 | −0.1 | −0.1 | 12 | 16 + 0 | negative | 46,XX | 46,XX | AC |
RDLN017192 | −1.2 | −0.4 | −1.0 | 13 | 16 + 1 | negative | 46,XY | 46,XY | AC |
RDLN017624 | 1.0 | 0.9 | 0.7 | 15 | 17 + 0 | negative | 46,XY | 46,XY | AC |
RDLN017641 | −1.0 | 0.3 | 0.7 | 8 | 15 + 2 | negative | 46,XY | 46,XY | AC |
RDLN017670 | 0.8 | 0.1 | −0.9 | 24 | 17 + 1 | negative | 46,XX | 46,XX | AC |